Launch your lab into the future with automated LC-MS/MS

LC-MS/MS is recognized as gold-standard technology for many applications in the clinical laboratory. In this two-part webinar, hear from clinical chemistry experts Dr. Andrew Davison and Dr. Rachel Carling on why LC-MS/MS is needed to advance clinical laboratory medicine.

Kicking off the session, Davison will focus on personalized medicine needs and how mass spectrometry can make a difference in the laboratory service. Following this, Carling will highlight how easy it can be to implement fully automated LC-MS/MS technology in a routine clinical laboratory workflow, through an evaluation of the first fully automated clinical analyzer based on LC-MS/MS: the Cascadion SM Clinical analyzer¹.

Part 1: Has mass spectrometry got the answers personalized medicine needs?

Presented by Dr. Andrew Davison, Consultant Clinical Scientist and Clinical Lead for R&D, Liverpool University Teaching Hospitals, Liverpool, UK

Part 2: Evaluation of the Thermo Scientific™ Cascadion™ SM Clinical Analyzer in the clinical laboratory: Vitamin D and immunosuppressant drugs

Presented by Dr. Rachel Carling, Consultant Scientist and Director of Biochemical Sciences, Viapath-St Thomas’ Hospital, London, UK

Key learning objectives:

• Advantages of LC-MS/MS technology in the clinical laboratory
• Whether mass spectrometry has the answers for personalized medicine needs
• How the Cascadion SM Clinical Analyzer can provide a turnkey solution for clinical labs to easily access the power of LC-MS/MS
• LC-MS/MS applications: Vitamin D and the therapeutic pharmacological drug monitoring of immunosuppressants

Who should attend:

• Clinical, hospital, and reference laboratory stakeholders
• Laboratory directors, laboratory managers, quality managers, information technology managers
• Clinical laboratory scientists and technicians

[1]-Thermo Fisher Scientific products are distributed globally so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status.